Abstract:Motivation: Computational drug repositioning is an important and efficient approach towards identifying novel treatments for diseases in drug discovery. The emergence of large-scale, heterogeneous biological and biomedical datasets has provided an unprecedented opportunity for developing computational drug repositioning methods. The drug repositioning problem can be modeled as a recommendation system that recommends novel treatments based on known drug-disease associations. The formulation under this recommendation system is matrix completion, assuming that the hidden factors contributing to drug-disease associations are highly correlated and thus the corresponding data matrix is low-rank. Under this assumption, the matrix completion algorithm fills out the unknown entries in the drug-disease matrix by constructing a low-rank matrix approximation, where new drug-disease associations having not been validated can be screened.Results: In this work, we propose a drug repositioning recommendation system (DRRS) to predict novel drug indications by integrating related data sources and validated information of drugs and diseases. Firstly, we construct a heterogeneous drug-disease interaction network by integrating drug-drug, disease-disease and drug-disease networks. The heterogeneous network is represented by a large drug-disease adjacency matrix, whose entries include drug pairs, disease pairs, known drug-disease interaction pairs and unknown drug-disease pairs. Then, we adopt a fast Singular Value Thresholding (SVT) algorithm to complete the drug-disease adjacency matrix with predicted scores for unknown drug-disease pairs. The comprehensive experimental results show that DRRS improves the prediction accuracy compared with the other state-of-the-art approaches. In addition, case studies for several selected drugs further demonstrate the practical usefulness of the proposed method.Availability and implementation: http://bioinformatics.csu.edu.cn/resources/softs/DrugRepositioning/DRRS/index.html.Contact: yaohang@cs.odu.edu or jxwang@mail.csu.edu.cn.Supplementary information: Supplementary data are available at Bioinformatics online.

DrugCLIP: Contrastive Drug-Disease Interaction For Drug Repurposing

Human and Machine Intelligence Together Drive Drug Repurposing in Rare Diseases

Drug repositioning based on the heterogeneous information fusion graph convolutional network

Clinical connectivity map for drug repurposing: using laboratory tests to bridge drugs and diseases

DrugRepo: a novel approach to repurposing drugs based on chemical and genomic features

Multimodal Protein-Ligand Contrastive Pretraining for Effective and Efficient Drug Discovery

DrugRepPT: a Deep Pre-Training and Fine-Tuning Framework for Drug Repositioning Based on Drug's Expression Perturbation and Treatment Effectiveness.

Drug Repositioning by Multi-Aspect Heterogeneous Graph Contrastive Learning and Positive-Fusion Negative Sampling Strategy

When deep learning meets causal inference: a computational framework for drug repurposing from real-world data

A Computational Strategy for Drug Repositioning Based on Support-Vector Regression Algorithm

Computational drug repositioning using low-rank matrix approximation and randomized algorithms

DrugReAlign: a multisource prompt framework for drug repurposing based on large language models

A weighted bilinear neural collaborative filtering approach for drug repositioning

A novel efficient drug repurposing framework through drug-disease association data integration using convolutional neural networks

Knowledge-driven drug repurposing using a comprehensive drug knowledge graph

Deep graph contrastive learning model for drug-drug interaction prediction

DrugRepoBank: a comprehensive database and discovery platform for accelerating drug repositioning

CLDR: Contrastive Learning Drug Response Models from Natural Language Supervision

Drug repositioning based on comprehensive similarity measures and Bi-Random walk algorithm

deepDR: a network-based deep learning approach to in silico drug repositioning

DrugCLIP: Contrastive Protein-Molecule Representation Learning for Virtual Screening